These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9511182)
1. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Hughes NC; Janezic SA; McQueen KL; Jewett MA; Castranio T; Bell DA; Grant DM Pharmacogenetics; 1998 Feb; 8(1):55-66. PubMed ID: 9511182 [TBL] [Abstract][Full Text] [Related]
2. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Butcher NJ; Ilett KF; Minchin RF Pharmacogenetics; 1998 Feb; 8(1):67-72. PubMed ID: 9511183 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel allele at the human NAT1 acetyltransferase locus. Doll MA; Jiang W; Deitz AC; Rustan TD; Hein DW Biochem Biophys Res Commun; 1997 Apr; 233(3):584-91. PubMed ID: 9168895 [TBL] [Abstract][Full Text] [Related]
4. Human acetyltransferase polymorphisms. Grant DM; Hughes NC; Janezic SA; Goodfellow GH; Chen HJ; Gaedigk A; Yu VL; Grewal R Mutat Res; 1997 May; 376(1-2):61-70. PubMed ID: 9202739 [TBL] [Abstract][Full Text] [Related]
5. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants. Payton MA; Sim E Biochem Pharmacol; 1998 Feb; 55(3):361-6. PubMed ID: 9484803 [TBL] [Abstract][Full Text] [Related]
6. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359 [TBL] [Abstract][Full Text] [Related]
8. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173 [TBL] [Abstract][Full Text] [Related]
9. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250 [TBL] [Abstract][Full Text] [Related]
10. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli. Dupret JM; Goodfellow GH; Janezic SA; Grant DM J Biol Chem; 1994 Oct; 269(43):26830-5. PubMed ID: 7929420 [TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster. Ferguson RJ; Doll MA; Rustan TD; Hein DW Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861 [TBL] [Abstract][Full Text] [Related]
12. Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice. Sugamori KS; Brenneman D; Grant DM Drug Metab Dispos; 2011 May; 39(5):882-90. PubMed ID: 21317369 [TBL] [Abstract][Full Text] [Related]
13. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Grant DM; Blum M; Beer M; Meyer UA Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083 [TBL] [Abstract][Full Text] [Related]
14. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition. Fretland AJ; Doll MA; Zhu Y; Smith L; Leff MA; Hein DW Cancer Detect Prev; 2002; 26(1):10-4. PubMed ID: 12088197 [TBL] [Abstract][Full Text] [Related]
15. N-acetyl transferase 1: two polymorphisms in coding sequence identified in colorectal cancer patients. Hubbard AL; Moyes C; Wyllie AH; Smith CA; Harrison DJ Br J Cancer; 1998 Mar; 77(6):913-6. PubMed ID: 9528834 [TBL] [Abstract][Full Text] [Related]
16. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis. Sy SK; de Kock L; Diacon AH; Werely CJ; Xia H; Rosenkranz B; van der Merwe L; Donald PR Antimicrob Agents Chemother; 2015 Jul; 59(7):4129-38. PubMed ID: 25963985 [TBL] [Abstract][Full Text] [Related]
17. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162 [TBL] [Abstract][Full Text] [Related]